Cargando…

Low-Density-Lipoprotein Particle Size Predicts a Poor Outcome in Patients with Atherothrombotic Stroke

BACKGROUND AND PURPOSE: Low-density lipoprotein (LDL) particle size is considered to be one of the more important cardiovascular risk factors, and small LDL particles are known to have atherogenic potential. The aim of this study was to determine whether LDL particle size is associated with stroke s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Tae-Jin, Cho, Hyun-Ji, Chang, Yoonkyung, Youn, Minjung, Shin, Min-Jeong, Jo, Inho, Heo, Ji Hoe, Kim, Yong-Jae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Neurological Association 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302183/ https://www.ncbi.nlm.nih.gov/pubmed/25628741 http://dx.doi.org/10.3988/jcn.2015.11.1.80

Ejemplares similares

Low Plasma Proportion of Omega 3-Polyunsaturated Fatty Acids Predicts Poor Outcome in Acute Non-Cardiogenic Ischemic Stroke Patients
por: Song, Tae-Jin, et al.
Publicado: (2015)

Unexplored Roles of Erythrocytes in Atherothrombotic Stroke
por: Papadopoulos, Charalampos, et al.
Publicado: (2023)

Low-density lipoprotein particle size in hepatic steatosis and metabolic syndrome
por: Kim, Dal-Sik, et al.
Publicado: (2010)

MRAS Genetic Variation Is Associated with Atherothrombotic Stroke in the Han Chinese Population
por: Liu, Hua, et al.
Publicado: (2013)

The Role of Biomarkers in Atherothrombotic Stroke—A Systematic Review
por: Andone, Sebastian, et al.
Publicado: (2021)

High Density Lipoprotein Particle Size in Children: Relation to Atherogenic Dyslipidemia
por: Numata, Michio
Publicado: (2004)

Association between triglyceride-glucose index and low-density lipoprotein particle size in korean obese adults
por: Kim, Sanghoon, et al.
Publicado: (2023)

Serum semaphorin 7A is associated with the risk of acute atherothrombotic stroke
por: You, Tao, et al.
Publicado: (2019)

The Relationship between Daily Fructose Consumption and Oxidized Low-Density Lipoprotein and Low-Density Lipoprotein Particle Size in Children with Obesity
por: Gungor, Ali, et al.
Publicado: (2021)

Association of triglyceride/high-density lipoprotein cholesterol ratio with severe complications of COVID-19
por: Chang, Yoonkyung, et al.
Publicado: (2023)

Adiponectin and Lipoprotein Particle Size
por: Weiss, Ram, et al.
Publicado: (2009)

The Effect of Insulin Resistance and Obesity on Low−Density Lipoprotein Particle Size in Children
por: Taşcılar, Mehmet Emre, et al.
Publicado: (2010)

Novel Therapeutic Approaches to Prevent Atherothrombotic Ischemic Stroke in Patients with Carotid Atherosclerosis
por: Puig, Núria, et al.
Publicado: (2023)

Antiplatelet combinations for prevention of atherothrombotic events
por: Bollati, Mario, et al.
Publicado: (2011)

Novel Antiplatelet Therapies for Atherothrombotic Diseases
por: Majithia, Arjun, et al.
Publicado: (2019)

Hematopoiesis of Indeterminate Potential and Atherothrombotic Risk
por: Murphy, Andrew J., et al.
Publicado: (2022)

PCSK9 as an Atherothrombotic Risk Factor
por: Sotler, Tadeja, et al.
Publicado: (2023)

High-density lipoprotein (HDL) particle size and concentration changes in septic shock patients
por: Tanaka, Sébastien, et al.
Publicado: (2019)

Low-density lipoprotein particles in atherosclerosis
por: Qiao, Ya-Nan, et al.
Publicado: (2022)

Pravastatin Reduces the Risk of Atherothrombotic Stroke when Administered within Six Months of an Initial Stroke Event
por: Hosomi, Naohisa, et al.
Publicado: (2018)

High Actin Expression in Thrombus of Acute Ischemic Stroke Can Be a Biomarker of Atherothrombotic Origin Stroke
por: Wang, Rongyu, et al.
Publicado: (2022)

Hemoglobin level and lipoprotein particle size
por: Hämäläinen, Päivi, et al.
Publicado: (2018)

High CD3+ Cells in Intracranial Thrombi Represent a Biomarker of Atherothrombotic Stroke
por: Dargazanli, Cyril, et al.
Publicado: (2016)

Environmental noise exposure is associated with atherothrombotic risk
por: Koczorowski, Magali, et al.
Publicado: (2022)

Role of Oxidative Stress in the Pathogenesis of Atherothrombotic Diseases
por: Petrucci, Giovanna, et al.
Publicado: (2022)

Associations between high density lipoprotein mean particle size and serum paraoxonase-1 activity
por: Razavi, Amirnader Emami, et al.
Publicado: (2012)

High-density lipoprotein subclass and particle size in coronary heart disease patients with or without diabetes
por: Tian, Li, et al.
Publicado: (2012)

Lipid core nanoparticles resembling low-density lipoprotein and regression of atherosclerotic lesions: effects of particle size
por: Freitas, S.C.M.P., et al.
Publicado: (2018)

The effects of fat consumption on low-density lipoprotein particle size in healthy individuals: a narrative review
por: Froyen, Erik
Publicado: (2021)

Pharmacogenomics of Cardiovascular Drugs for Atherothrombotic, Thromboembolic and Atherosclerotic Risk
por: Mauriello, Alfredo, et al.
Publicado: (2023)

Lack of Association Between Low Density Lipoprotein Particle Size and On-Treatment Platelet Reactivity in Patients With Coronary Artery Disease
por: Kang, Do-Yoon, et al.
Publicado: (2012)

Small Dense Low Density Lipoprotein Particles Are Associated with Poor Outcome after Angioplasty in Peripheral Artery Disease
por: Jacomella, Vincenzo, et al.
Publicado: (2014)

Association between metabolic syndrome and multiple lesions of intracranial atherothrombotic stroke: a hospital-based study
por: Kotani, Kazuhiko, et al.
Publicado: (2015)

Sleep Status and Low-Density Lipoprotein Particle Size in a General Japanese Female Population: The Mima Study
por: Kotani, Kazuhiko, et al.
Publicado: (2013)

Triglyceride-Rich Lipoproteins and Remnant Cholesterol in Cardiovascular Disease
por: Heo, Ji Hye, et al.
Publicado: (2023)

Beneficial Effects of Omega-3 Fatty Acids on Low Density Lipoprotein Particle Size in Patients with Type 2 Diabetes Already under Statin Therapy
por: Lee, Myung Won, et al.
Publicado: (2013)

Role of oral anticoagulant therapy for secondary prevention in patients with stable atherothrombotic disease manifestations
por: Cho, Sung Won, et al.
Publicado: (2019)

Microcirculation and atherothrombotic parameters in prolactinoma patients: a pilot study
por: Reuwer, Anne Q., et al.
Publicado: (2011)

Medicinal Herbals with Antiplatelet Properties Benefit in Coronary Atherothrombotic Diseases
por: Mohd Nor, Nurul Huda, et al.
Publicado: (2016)

Oxidative Stress in the Pathogenesis of Antiphospholipid Syndrome: Implications for the Atherothrombotic Process
por: Nocella, Cristina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_amguq74feb8534kpir81qk64il